Self Amplifying RNA Vaccines Patent Landscape and Forecast Report 2024-2032, Featuring Gentech, Novartis, Human Genome Sciences, Immatics Biotechnologies and Broad Institute
12. November 2024 11:25 ET
|
Research and Markets
Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Self Amplifying RNA Vaccines Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The self...
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
07. November 2024 08:00 ET
|
HilleVax, Inc.
$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in...
United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts 2019-2023 & 2024-2033
29. Oktober 2024 10:59 ET
|
Research and Markets
Dublin, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The "United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to...
2024 Research | Vaccine Delivery Devices Market Poised for Remarkable Growth, Expected to Reach $9.45 Billion by 2028
04. Oktober 2024 09:06 ET
|
Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Delivery Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. In a significant development for the...
Pneumococcal Vaccine Research Report 2024: Market Expected to Reach $12.932 Billion by 2029
25. September 2024 10:22 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Pneumococcal Vaccines Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The global pneumococcal...
Pneumococcal Vaccine Market Research 2024-2030: Prevnar 13, VAXNEUVANCE, PNEUMOSIL Size, Share & Trends Analysis
06. September 2024 07:17 ET
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Global Pneumococcal Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type, Product (Prevnar 13, VAXNEUVANCE, PNEUMOSIL), End-use...
2024 Market Research: Vaccines Market Projected to Reach USD 116.63 Billion by 2027 - Rising Disease Prevalence and Prophylactic Applications Fueling Growth
06. September 2024 05:57 ET
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The global...
Vaccine Adjuvants Strategic Research Report 2024
05. September 2024 04:05 ET
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Vaccine...
Global Cholera Vaccines Market - Global Inactivated Vaccine, Live Attenuated Vaccine, Injectable Vaccines, Oral Vaccines Forecast 2024-2030
30. August 2024 04:05 ET
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines),...
Dengue Vaccine Research Report 2024 with Focus on 40+ Players Including Biological E, GSK, Instituto Butantan, Panacea Biotec, Sanofi, Takeda, Vabiotech - Market Forecast to 2030
28. August 2024 11:07 ET
|
Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Dengue Vaccine - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Dengue Vaccine was...